|
1
|
Soerjomataram I, Lortet-Tieulent J, Parkin
DM, Ferlay J, Mathers C, Forman D and Bray F: Global burden of
cancer in 2008: A systematic analysis of disability-adjusted
life-years in 12 world regions. Lancet. 380:1840–1850. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Clegg LX, Ward E, Ries LA, Wu X,
Jamison PM, Wingo PA, Howe HL, Anderson RN and Edwards BK: Annual
report to the nation on the status of cancer, 1975–2001, with a
special feature regarding survival. Cancer. 101:3–27. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doi T, Piha-Paul SA, Jalal SI, Saraf S,
Lunceford J, Koshiji M and Bennouna J: Safety and antitumor
activity of the anti-programmed death-1 antibody pembrolizumab in
patients with advanced esophageal carcinoma. J Clin Oncol.
36:61–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giri S, Pathak R, Aryal MR, Karmacharya P,
Bhatt VR and Martin MG: Incidence trend of esophageal squamous cell
carcinoma: An analysis of Surveillance Epidemiology and End Results
(SEER) database. Cancer Causes Control. 26:159–161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang J, Zhi C, Zhen F, Yuan X, Jiao C,
Zhu H, Zhu H and Feng Y: iTRAQ-based quantitative proteomic
analyses of high grade esophageal squamous intraepithelial
neoplasia. Proteomics Clin Appl. Dec 11–2017.(Epub ahead of print).
doi: 10.1002/prca.201600167. View Article : Google Scholar
|
|
9
|
Hsu CH, Hsu CW, Hsueh C, Wang CL, Wu YC,
Wu CC, Liu CC, Yu JS, Chang YS and Yu CJ: Identification and
characterization of potential biomarkers by quantitative tissue
proteomics of primary lung adenocarcinoma. Mol Cell Proteomics.
15:2396–2410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rice TW: Esophageal cancer staging. Korean
J Thorac Cardiovasc Surg. 48:157–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Young J, Badgery-Parker T, Dobbins T,
Jorgensen M, Gibbs P, Faragher I, Jones I and Currow D: Comparison
of ECOG/WHO performance status and ASA score as a measure of
functional status. J Pain Symptom Manage. 49:258–264. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bandaranayake AD, Correnti C, Ryu BY,
Brault M, Strong RK and Rawlings DJ: Daedalus: A robust, turnkey
platform for rapid production of decigram quantities of active
recombinant proteins in human cell lines using novel lentiviral
vectors. Nucleic Acids Res. 39:e1432011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta DeltaC (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Herskovic A, Russell W, Liptay M, Fidler
MJ and Al-Sarraf M: Esophageal carcinoma advances intreatment
results for locally advanced disease: Review. Ann Oncol.
23:1095–1103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li BZ, Chen ZL, Shi SS, Feng XL, Tan XG,
Zhou F and He J: Overexpression of Cdc25C predicts response to
radiotherapy and survival in esophageal squamous cell carcinoma
patients treated with radiotherapy followed by surgery. Chin J
Cancer. 32:403–409. 2013.PubMed/NCBI
|
|
17
|
Sugase T, Takahashi T, Serada S, Fujimoto
M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T,
Kurokawa Y, et al: SOCS1 gene therapy improves radiosensitivity and
enhances irradiation-induced DNA damage in esophageal squamous cell
carcinoma. Cancer Res. 77:6975–6986. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamaoki M, Komatsuzaki R, Komatsu M,
Minashi K, Aoyagi K, Nishimura T, Chiwaki F, Hiroki T, Daiko H,
Morishita K, et al: Multiple roles of single-minded 2 in esophageal
squamous cell carcinoma and its clinical implications. Cancer Sci.
109:1121–1134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shigaki H, Baba Y, Watanabe M, Murata A,
Ishimoto T, Iwatsuki M, Iwagami S, Nosho K and Baba H: PIK3CA
mutation is associated with a favorable prognosis among patients
with curatively resected esophageal squamous cell carcinoma. Clin
Cancer Res. 19:2451–2459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hannigan GE, Leung-Hagesteijn C,
Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar
S: Regulation of cell adhesion and anchorage-dependent growth by a
new beta 1-integrin-linked protein kinase. Nature. 379:91–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong RP, Ng P, Dedhar S and Li G: The role
of integrin-linked kinase in melanoma cell migration, invasion and
tumor growth. Mol Cancer Ther. 6:1692–1700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhuang X, Lv M, Zhong Z, Zhang L, Jiang R
and Chen J: Interplay between intergrin-linked kinase and
ribonuclease inhibitor affects growth and metastasis of bladder
cancer through signaling ILK pathways. J Exp Clin Cancer Res.
35:1302016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen H, Ma JL, Zhang Y, Deng GL, Qu YL, Wu
XL, He JX, Zhang S and Zeng S: Integrin-linked kinase
overexpression promotes epithelial-mesenchymal transition via
nuclear factor-κB signaling in colorectal cancer cells. World J
Gastroenterol. 22:3969–3977. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Driver GA and Veale RB: Modulation of
integrin-linked kinase (ILK) expression in human oesophageal
squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth
factors. Cancer Cell Int. 6:122006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mohamed MS, Bishr MK, Almutairi FM and Ali
AG: Inhibitors of apoptosis: Clinical implications in cancer.
Apoptosis. 22:1487–1509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duxbury MS, Ito H, Benoit E, Waseem T,
Ashley SW and Whang EE: RNA interference demonstrates a novel role
for integrin-linked kinase as a determinant of pancreatic
adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res.
11:3433–839. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lanvin O, Monferran S, Delmas C, Couderc
B, Toulas C and Cohen-Jonathan-Moyal E: Radiation-induced mitotic
cell death and glioblastoma radioresistance: A new regulating
pathway controlled by integrin-linked kinase, hypoxia-inducible
factor 1 alpha and survivin in U87 cells. Eur J Cancer.
49:2884–2891. 2013. View Article : Google Scholar : PubMed/NCBI
|
